Detalles de la búsqueda
1.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Clin Infect Dis
; 76(4): 674-682, 2023 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35906831
2.
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
J Antimicrob Chemother
; 78(8): 1813-1826, 2023 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311136
3.
Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus.
Ann Hematol
; 101(3): 491-511, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994811
4.
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial.
Haematologica
; 106(2): 543-554, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107341
5.
State of Medical Mycology at German Academic Medical Centres: A Survey of the German-Speaking Mycological Society (DMYKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG).
Mycoses
; 64(10): 1177-1182, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34180098
6.
Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.
Med Mycol
; 58(4): 417-424, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31613363
7.
Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia.
Mycoses
; 63(10): 1101-1106, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738006
8.
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Mycoses
; 63(7): 653-682, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236989
9.
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
J Antimicrob Chemother
; 74(11): 3315-3327, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31393591
10.
Diagnostic work up to assess early response indicators in invasive pulmonary aspergillosis in adult patients with haematologic malignancies.
Mycoses
; 62(6): 486-493, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30329192
11.
A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.
J Clin Microbiol
; 56(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29187564
12.
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Mycoses
; 61(11): 868-876, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30035825
13.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet
; 387(10020): 760-9, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26684607
14.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3406-3413, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961714
15.
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
Med Mycol
; 55(4): 375-384, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27703016
16.
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.
Ann Hematol
; 95(9): 1435-55, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339055
17.
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.
Med Mycol
; 54(2): 128-37, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26483433
18.
Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.
Mycoses
; 59(8): 480-93, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324802
19.
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Ann Intern Med
; 162(2): 81-9, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25599346
20.
Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative.
J Clin Microbiol
; 53(9): 2832-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26085618